Orthostatic Hypotension in Benign Prostatic Hyperplasia Patients and Its Association With Alpha-1 Antagonist Use: A Comprehensive Literature Review.
alpha-1 adrenergic antagonists
benign prostatic hyperplasia
lower urinary tract symptoms
orthostatic hypotension
quality of life
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
25
08
2023
medline:
26
9
2023
pubmed:
26
9
2023
entrez:
26
9
2023
Statut:
epublish
Résumé
Orthostatic hypotension (OH) is frequently observed in benign prostatic hyperplasia (BPH) patients undergoing alpha-1 adrenergic antagonist (A1AA) therapy. While previous studies have acknowledged the prevalence of OH in BPH patients on A1AAs, limited data exist on ranking the safety of different A1AAs. This comprehensive review explores the underlying mechanisms of OH, examines numerous factors influencing its development, and provides insights into effective treatment strategies such as hydration, gradual postural changes, leg exercises, compression stockings, and tilt-table training for BPH management. The review highlights the significance of individualized care, interdisciplinary collaboration, and further research to optimize A1AA treatment, improve patient outcomes, and enhance quality of life.
Identifiants
pubmed: 37750139
doi: 10.7759/cureus.44097
pmc: PMC10518119
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e44097Informations de copyright
Copyright © 2023, Abubakar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 2):193-6
pubmed: 9474671
Rev Urol. 2007 Fall;9(4):181-90
pubmed: 18231614
Ther Adv Urol. 2021 Apr 12;13:1756287221993283
pubmed: 33912246
J Neurol. 2017 Aug;264(8):1567-1582
pubmed: 28050656
Cleve Clin J Med. 2010 May;77(5):298-306
pubmed: 20439562
Clin Med (Lond). 2021 May;21(3):e275-e282
pubmed: 34001585
J Urol. 2021 May;205(5):1430-1437
pubmed: 33616451
Pharmacol Res Perspect. 2021 Aug;9(4):e00799
pubmed: 34355529
Eur Urol. 2000 Mar;37(3):306-13
pubmed: 10720857
Rev Urol. 2005;7 Suppl 9:S3-S14
pubmed: 16985902
World J Clin Cases. 2022 Sep 6;10(25):9142-9147
pubmed: 36157672
Monaldi Arch Chest Dis. 2020 Nov 20;90(4):
pubmed: 33238696
Am J Hypertens. 2018 Jun 11;31(7):797-803
pubmed: 29617895
Urology. 2005 Oct;66(4):780-8
pubmed: 16230138
Circulation. 1999 Sep 7;100(10):1134-46
pubmed: 10477542
Asian J Androl. 2015 Nov-Dec;17(6):1022-32
pubmed: 25994648
J Am Coll Cardiol. 2015 Aug 18;66(7):848-860
pubmed: 26271068
Eur J Appl Physiol. 2003 May;89(3-4):263-70
pubmed: 12736834
Arch Intern Med. 1992 May;152(5):1066-72
pubmed: 1580710
PLoS One. 2017 Jan 10;12(1):e0169248
pubmed: 28072862
Neurology. 2006 Jul 11;67(1):28-32
pubmed: 16832073
Front Cardiovasc Med. 2022 Feb 10;9:834879
pubmed: 35224062
J Auton Pharmacol. 1996 Feb;16(1):21-8
pubmed: 8736427
Br J Urol. 1997 Oct;80(4):597-605
pubmed: 9352699
J Clin Neurol. 2015 Jul;11(3):220-6
pubmed: 26174784
Eur Heart J. 2011 Mar;32(5):590-7
pubmed: 21224291
Mov Disord Clin Pract. 2017 May-Jun;4(3):298-308
pubmed: 28713844
J Int Med Res. 2001 May-Jun;29(3):236-51
pubmed: 11471862
BJU Int. 2003 Aug;92(3):257-61
pubmed: 12887479
Drugs Aging. 2002;19(2):135-61
pubmed: 11950378
Urology. 2009 Dec;74(6):1318-22
pubmed: 19815265
Rev Urol. 2005;7 Suppl 4:S42-8
pubmed: 16986054
BMJ. 2013 Nov 05;347:f6320
pubmed: 24192967
Clin Interv Aging. 2011;6:161-72
pubmed: 21753871
J Am Soc Hypertens. 2013 Jul-Aug;7(4):317-24
pubmed: 23721882
Continuum (Minneap Minn). 2020 Feb;26(1):154-177
pubmed: 31996627
Ther Clin Risk Manag. 2007 Mar;3(1):181-96
pubmed: 18360626
Br J Pharmacol. 2019 Jul;176(14):2343-2357
pubmed: 30740663
Stroke. 2001 Jul;32(7):1546-51
pubmed: 11441199
Clin Auton Res. 2011 Apr;21(2):69-72
pubmed: 21431947
J Clin Pharmacol. 2015 Oct;55(10):1101-8
pubmed: 25903807
Neurology. 2015 Oct 20;85(16):1362-7
pubmed: 26400576
Ther Clin Risk Manag. 2008 Feb;4(1):11-8
pubmed: 18728700
World J Mens Health. 2021 Apr;39(2):186-194
pubmed: 32009306
Urology. 1998 Jun;51(6):892-900
pubmed: 9609623
Rev Urol. 2005;7 Suppl 4:S22-30
pubmed: 16986051
Prostate Int. 2017 Sep;5(3):113-118
pubmed: 28828355
Neurology. 1996 May;46(5):1470
pubmed: 8628505
J Physiol. 2003 Sep 1;551(Pt 2):401
pubmed: 12837932
Ther Adv Drug Saf. 2016 Feb;7(1):11-22
pubmed: 26834959
Front Physiol. 2012 Aug 07;3:314
pubmed: 22934064
Clin Auton Res. 2002 Aug;12(4):242-9
pubmed: 12357277
Clin Ther. 1997 Jul-Aug;19(4):730-42
pubmed: 9377617
Eur Urol. 1998;33 Suppl 2:19-27
pubmed: 9556192
J Clin Hypertens (Greenwich). 2005 Dec;7(12):757-62
pubmed: 16330901
J Intern Med. 2015 Jan;277(1):69-82
pubmed: 24697914
J Physiol. 2003 Sep 1;551(Pt 2):601-8
pubmed: 12813144
Urology. 2001 Mar;57(3):459-65
pubmed: 11248620
Circ Arrhythm Electrophysiol. 2022 Mar;15(3):e010573
pubmed: 35212554
Expert Opin Investig Drugs. 2007 Dec;16(12):1955-65
pubmed: 18042003
Gerontology. 2017;63(2):137-143
pubmed: 27756060
Med Sci Sports Exerc. 2015 Apr;47(4):843-9
pubmed: 25137367
Hypertension. 2004 Nov;44(5):776-82
pubmed: 15466664